In recent developments regarding U.S. trade policies, consumers and tech companies, particularly Apple, were relieved to learn that certain electronic products—including smartphones—were temporarily spared from hefty tariffs. However, this relief may be short-lived as the Commerce Secretary has indicated that new tariffs could soon replace the temporary exemptions.
Just yesterday, we reported that iPhone buyers in the U.S. would not face exorbitant prices for certain models, thanks to announcements from U.S. Customs and Border Protection. Selected tech products imported into the country, including smartphones and laptop computers, were granted exemptions from the reciprocal tariffs introduced by President Donald Trump earlier this month.
After Trump suspended the tariffs for 90 days on April 9th, the existing 125% import tax on goods shipped from China remained in place, alongside the baseline 10% tariff on other trading partners. The recent exemption for electronics created a moment of temporary relief for consumers and companies like Apple, but concerns arose about the long-term sustainability of this reprieve.
Commerce Secretary Howard Lutnick confirmed this morning on ABC's "This Week" that the temporary relief for smartphones and related products may soon come to an end. He noted that new "semiconductor tariffs" targeting items like smartphones could be introduced in the next month or two, transforming the current tariff landscape.
Stay updated with the latest Apple news and announcements.
By subscribing, you agree to our terms and conditions and privacy policy.
Lutnick explained that the intention behind these potential tariffs is to promote domestic production of crucial components like semiconductors and flat screens. He stated, "We need to have semiconductors, we need to have chips, and we need to have flat panels - we need to have these things made in America. We can't be reliant on Southeast Asia for all of the things that operate for us."
Furthermore, Lutnick mentioned that the administration is also considering tariffs on pharmaceuticals. Despite warnings from economists that these adjustments could negatively impact the U.S. economy, the administration remains committed to its strategic adjustments in trade policy.
